Trial Profile
The Effect of Z-338 in Subjects With Functional Dyspepsia, Evaluate the Function of Gastro-Duodenum by Ultrasound.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2012
Price :
$35
*
At a glance
- Drugs Acotiamide (Primary)
- Indications Non-ulcer dyspepsia
- Focus Pharmacodynamics; Therapeutic Use
- 29 Jun 2010 Planned end date changed from Mar 2010 to Jul 2010 as reported by ClinicalTrials.gov.
- 05 May 2010 Results reported at Digestive Disease Week.
- 05 May 2010 Status changed from active, no longer recruiting to completed, as results were reported at DDW.